Skip to main content

Table 1 The baseline demographic and clinical characteristics of patients with hyperkalemia

From: Clinical and electrocardiogram presentations of patients with high serum potassium concentrations within emergency settings: a prospective study

Variables Frequency (%)
Gender Male 28 (41.8)
Female 39 (58.2)
Age (mean ± SD): 63.90 ± 15.13
Smoking status Current smoker 15 (22.4)
Ex-smoker 8 (11.9)
Non-smoker 44 (65.7)
Place the patient came from Home 49 (73.1)
Transfer from another clinic 18 (26.9)
Mode of transport to the emergency department Walking 18 (26.9)
Private car 30 (44.8)
ambulance 19 (28.4)
Comorbidities HTN 48 (71.6)
DM 45 (67.2)
Chronic renal disease 43 (64.2)
IHD 17 (25.4)
CHF 13 (19.4)
Hypothyroidism 6 (9.0)
Stroke 5 (7.5)
Gout 5 (7.5)
Arterial fibrillation 5 (7.5)
Venous thromboembolism 4 (6.0)
COPD 1 (1.5)
Patients on regular dialysis 16 (23.9)
Medications ACEIs 21 (31.3)
ARBs 19 (28.4)
Beta-blockers 35 (52.2)
CCBs 28 (41.8)
Aspirin 34 (50.8)
Other NSAIDs 2 (3.0)
LMWH or unfractured heparin 5 (7.5)
Warfarin 5 (7.5)
PPIs 39 (58.2)
Statins 43 (64.2)
Metformin 12 (17.9)
Insulin 23 (34.3)
Levothyroxine 6 (9.0)
Allopurinol 4 (6.0)
Cortisol 5 (7.5)
Loop diuretics 15 (22.4)
Thiazide diuretics 7 (10.5)
Potassium-sparing diuretics 3 (4.5)
Digitalis 2 (3.0)
Clopidogrel 8 (11.9)
  1. Abbreviations: HTN Hypertension, DM Diabetes mellitus, IHD Ischemic heart disease, CHF Congestive heart failure, COPD Chronic obstructive pulmonary disease, ACEIs Angiotensin-converting enzyme inhibitors, ARBs Angiotensin-receptor blockers, CCBs Calcium channel blockers, NSAIDs Non-steroidal anti-inflammatory drugs, LMWH Low molecular weight heparin, PPIs Proton pump inhibitors